Pharmacological treatment trials of agitation in Alzheimer's disease: A systematic review of ClinicalTrials.gov registered trials

INTRODUCTION: There is increasing emphasis on the importance of optimizing and standardizing clinical trials of agitation in Alzheimer's disease (AD), but the risks of bias arising from published trials and the number and design of unpublished studies are poorly understood. METHODS: Using the C...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kathy Y., Borissova, Anya, Mahmood, Jansher, Elliott, Thomas, Knowles, Melanie, Bentham, Peter, Reeves, Suzanne, Howard, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010365/
https://www.ncbi.nlm.nih.gov/pubmed/33816763
http://dx.doi.org/10.1002/trc2.12157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010365/
https://www.ncbi.nlm.nih.gov/pubmed/33816763
http://dx.doi.org/10.1002/trc2.12157

Ejemplares similares